Invenia ABUS 2.0

Look differently at dense breast tissue

GE Healthcare offers the first FDA-approved ultrasound supplemental technology that is specifically designed for detecting cancer in dense breast tissue. Compared to mammography alone, Invenia ABUS 2.0 imaging looks differently at dense breast tissue, providing a comprehensive view of the breast.

At GE Healthcare, we are committed to helping clinicians use image guidance technologies to their full potential by removing barriers, in order to provide their patients quality care, for better clinical and operational outcomes.

Meet Allia IGS 5, your trusted assistant for image guided therapies.

Takes digital x-ray to the point of care.